DFX Intelligence

Data Factory

Excelsior Sciences

Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:5615cd8f-18fb-4dbe-92f8-a3200f13e19c

Data as of Sep 20, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 21, 2026, 5:34 AM UTC and rebuilt at most every 15 minutes.

Relationships: 4
Dated events: 0
On other graphs: 1
Observed: Sep 13, 2026 to Sep 20, 2026
6 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Excelsior Sciences

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 3
People: 0
Website: excelsiorsci.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
Sofinnova Partners	Multi stage VC	n/a	n/a	unknown	Unknown
Khosla Ventures, LLC	Multi stage VC	n/a	n/a	unknown	Unknown
Deerfield Management	Candidate VC	n/a	n/a	lead	Unknown
Khosla Ventures, LLC	Multi stage VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (3)

← Sofinnova PartnersFirmPortfolio listing
Sep 20, 2026 to presentfactThe subject's own site
← Khosla Ventures, LLCFirmPortfolio listing
Sep 20, 2026 to presentfactThe subject's own site
← Deerfield ManagementFirmPortfolio listing
Sep 20, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:5615cd8f-18fb-4dbe-92f8-a3200f13e19c
First observed: Sep 13, 2026
Last observed: Sep 20, 2026 19 h ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.